Evaluating Anemia Care Pathways to Assess and Manage Iron-Deficiency and Anemia in Patients with IBD

Although the incidence of anemia in patients with inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, has reportedly decreased in the last few decades, it is still the most prevalent extraintestinal complication of IBD.

Assessing the Impact of Anemia in Patients with IBD

Although the incidence of anemia in patients with inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, has reportedly decreased in the last few decades, it is still the most prevalent extraintestinal complication of IBD.

The Value of Biosimilars in the Treatment of IBD: Frequently Asked Questions

Biosimilars offer additional treatment options for patients with IBD. In this activity, faculty will review the role of biosimilars in the management of IBD and answer learner questions from the previous CME activity.